Sign in
Not yet recruitingNo phase

Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery

Key facts

Who runs it
Democritus University of Thrace
Where
Greece1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
300 people, planned
Started
1 May 2026
Expected to end
1 May 2027
Type of study
Observational, 3 groups
Treatments tested
  • Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
  • Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
  • Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)
Record updated
12 May 2026

Who can take part

Age
45 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (5)Hide the full registry criteria

Who can take part

  • Diagnosis of senile cataract with stage 2 or 3 nuclear opalescence according to the - Lens Opacities Classification System III (LOCS-3) grading scale

Who cannot take part

  • Former incisional surgery
  • Former diagnosis of corneal disease
  • Autoimmune diseases
  • Mental diseases

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Cataract or dry eye

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary objective of this study is the assessment of three tear substitute formulations in terms of postoperative discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

The 3 groups in the trial

  • Study Group 1

    Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)

    Treatment: Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)

  • Study Group 2

    Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)

    Treatment: Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)

  • Study Group 3

    Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)

    Treatment: Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery: A Non- Interventional, Observational Study
Criteria questions
Built from NCT07581548, who can take part
Record updated
12 May 2026